MediPharm Labs Corp. (TSE:LABS – Get Free Report) was up 16.7% during mid-day trading on Tuesday . The stock traded as high as C$0.07 and last traded at C$0.07. Approximately 228,256 shares traded hands during trading, an increase of 15% from the average daily volume of 198,012 shares. The stock had previously closed at C$0.06.
MediPharm Labs Price Performance
The firm has a market capitalization of C$28.77 million, a P/E ratio of -1.75 and a beta of 0.89. The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The business’s 50 day moving average is C$0.07 and its 200-day moving average is C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- What Are Some of the Best Large-Cap Stocks to Buy?
- What’s Next After FOMC’s Aggressive Interest Rate Cuts?
- Conference Calls and Individual Investors
- Verizon Stock: 5G Boom and Robust Dividend Yield at Play
- What is the Hang Seng index?
- 3 Stocks with Upgraded Ratings: Analysts Predict More Upside
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
